Home LiteratureArticle Details
PMID: 14505801 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents.

Biochemical pharmacology ·Vol. 66 ·No. 7 ·2003-10-01 ·Pages 1219-29

Raghunand N, Mahoney BP, Gillies RJ

Abstract

Ion-trapping theory predicts that alkalinization of tumor extracellular pH will enhance the anti-tumor activity of weak-base chemotherapeutics. We have previously demonstrated that chronic and acute treatment of tumor-bearing mice with sodium bicarbonate results in tumor-specific alkalinization of extracellular pH. Furthermore, bicarbonate pretreatment enhances the anti-tumor activity of doxorubicin and mitoxantrone in two different mouse tumor models. Previous work has indicated subtle, yet significant differences between the pH sensitivities of the biodistribution and anti-tumor efficacies of doxorubicin and mitoxantrone in vitro. The present study demonstrates that systemic alkalinization selectively enhances tumor uptake of radiolabeled mitoxantrone, but not doxorubicin. Results using these two drugs are quantitatively and qualitatively very different, and can be explained on the basis of differences in the octanol-water partition coefficients of their charged forms. These results suggest that inducing metabolic alkalosis in patients would have a positive effect on response to mitoxantrone therapy. However, the therapeutic index would not increase if sodium bicarbonate also caused increased retention of mitoxantrone in susceptible normal tissues in the host. The major dose-limiting organ systems for mitoxantrone are heart, liver, bone marrow, spleen and blood cells. Bicarbonate was found to have no significant effect on the distribution of mitoxantrone to any of these tissues except for spleen. However, neither spleen weights nor lymphocyte counts were adversely affected by NaHCO(3) pretreatment, indicating that this co-therapy does not enhance myelosuppression due to mitoxantrone therapy. These findings suggest that metabolic alkalosis would produce a net gain in mitoxantrone therapeutic index.

MeSH Terms
Animals Antineoplastic Agents/pharmacokinetics,pharmacology,therapeutic use Cell Division/drug effects Doxorubicin/pharmacokinetics,pharmacology,therapeutic use Humans Hydrogen-Ion Concentration Mice Mice, Inbred C3H Mitoxantrone/pharmacokinetics,pharmacology,therapeutic use Neoplasm Transplantation Neoplasms, Experimental/drug therapy Tissue Distribution Xenograft Model Antitumor Assays
Chemicals
Antineoplastic Agents Doxorubicin Mitoxantrone
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Raghunand Natarajan
Department of Biochemistry and Cancer Biology Program, Arizona Cancer Center, University of Arizona Health Sciences Center, Tucson, AZ 85724-5024, USA. raghunan@U.Arizona.Edu
Mahoney Brent P
Gillies Robert J
Article Info
Journal
Biochemical pharmacology
Abbr.
Biochem Pharmacol
ISSN
0006-2952
Published
2003-10-01
Pages
1219-29
Language
English
Region
England
NLM ID
0101032
Subset
IM
Grants
NCI NIH HHS · R01 CA77575 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com